Velandy Manohar, MD

Fostering Recovery By Increasing Understanding of Mental Illness


  • Home
  • Response to Recent Events in the United States
  • Sources of Solace, Strength, Insight and Inspiration
  • 25 Essential Morning Prayers
  • Dharma - Short Prayer
  • Dharma Prayers 2-7-21
  • Services Provided
  • Common Questions
  • Rates & Insurance
  • Helpful Forms
  • Links & Resources
  • Contact Me
  • Privacy & Policy
  • Hot Topics!
  • Links & Resources
  • Mahatma Gandhi
  • Mahatma Gandhi and the UNO
  • Global Warming Formulating and implementing a coordinated response to an imminent Existential threat
  • Readings for Meditation and inspirational prayers
  • Sanatana Dharma-P2P-Pedro Ruiz
  • Dharma - Shiva Ananda Lahari Commentary
  • Mahatma Gandhiji-Chronology of a blesssed life
  • Mahatma Gandhiji- His life and Message in his own words
  • Mahatma Gandhiji-Principles and Practice of Satyagraha
  • Mahatma Gandhiji- Views on Religious Conversion
  • Mahatma Gandhiji- Spiritual and Psychological Perspectives
  • Mahatma Gandhi 151st Birth Anniversary
  • Compendium of Videos and Posts Updated 10 28 19
  • P2P Psychiatric Delegation Report
  • Corona Virus Prevalence
  • Covid 19: Foundational Data to develop Policies
  • COVID-19 Testing, Key issues on Reliability of results for Clinical interventions and Policy development
  • Corona Virus Testing Challenges must be swiftly addressed
  • COVID-19 Countermeasures
  • COVID-19 Public Education Poster and Telehealth Interventions
  • Covid 19: Why 'Exponential Growth' Is So Scary
  • COVID-19 Policy Implemented In Belgium
  • COVID-19 Impact on Residents of Belgian Nursing Homes
  • COVID-19 Impact of Policies on Seniors in Belgium, Sweden
  • COVID-19 Potential for devastating effects when Social Isolation and Loneliness merges with the Debilitating effects of the Pandemic under the Malignant Ageism Regime in Belgium
  • Importance of COVID-19 Vaccination for Residents of Long-term Care Facilities
  • Covid 19: Vaccination Strategy & Immunization
  • Covid vaccines should go first to health care workers, long term care facility residents
  • COVID-19 DEATHS BY RACE AND ETHNICITY IN THE U.S.
  • More Than 100,000 People Died Of COVID-19 In Nursing Homes, Findings Show : NPR
  • enhancing care of and protecting the lives of our seniors and disabled individuals living in Nursing homes
  • Both Doses of COVID-19 Vaccines Needed, FDA Says
  • Protective immunity against SARS-CoV-2 could last eight months or more
  • NIHCM Newsletter: Chronic Disease, Mental Health & COVID-19
  • COVID-19 R Number & Spread in USA
  • Why 'Exponential Growth' Is So Scary For The COVID-19 Coronavirus
  • COVID-19 Vaccinations - Alternative Testing Options
  • establishing policies for requiring COVID -19 Vaccinations
  • SARS-CoV-2 Transmission From People Without COVID-19 Symptoms
  • Learning from Excess Pandemic Deaths
  • COVID -19 – Vaccination Policies pursued by Govt at all three Levels
  • You Asked, We’re Answering: Your Top Questions about Covid-19 and Vaccines
  • COVID19 Multiple Foundational Reports
  • CDC Alarmed: 74% of Cases in Cape Cod Cluster Were Among the Vaxxed
  • COVID-19: Managing Response to Policy on Vaccinations
  • COVID19-Information from Yale Medicine on Delta variant, common fallacies and how to address misinformation
  • Immune System
  • Inflammation-Top 5 Blood Tests
  • The Human Family
  • Martin Luther King Tribute
  • Right is Right, Even if Everyone Disagrees
  • "We Can't Breathe"
  • Levels of Racism: A Theoretic Framework and a Gardener’s Tale
  • Racism and Health - CDC Reports
  • Sullivan Report: Missing Persons: Minorities in the Health Professions
  • Satyam Eva Jayate- Truth alone prevails.
  • Hospice Training
  • What is a "Good Death"?
  • Fairfield County’s role in the Underground Railroad and early abolition movements.
  • HOLY MATRIMONY
  • America the Beautiful
  • Architecture of Inequality
  • Racism & Health - Disparities
  • Civil War: Letters & Materials
  • Culture Race & Disparities
  • Black Men 2.5 Times More likely than White Men to be Killed by Police
  • Disparities: Anti Racism
  • Disparities and Injustice: Crossing Generations.
  • Disparities: Multiple Articles
  • Disparities: Key reports from Professor David R. Williams
  • Resources on Racism
  • Martin Luther King, Jr. Riverside Church
  • Dr. King’s Beloved Community
  • Social Determinants of Health
  • Oak Creek Community Marks Two Years since Sikh Temple Shooting
  • Race and Race Based Discrimination
  • Race Based Prejudice
  • Criminal Justice Fact Sheet
  • Race, Culture & Urban Design
  • Race-Architecture of White Supremacy
  • The Nation: The Reconstruction-Era Violence Lurking in the Southern Air
  • Meaning behind the Juneteenth flag symbols - CNN
  • Malefic Murders of African Americans
  • How Slavery Haunts Today's America
  • V.A. Issues Employee Vaccine Mandate, a First for a Federal Agency
  • Juneteenth & Multiple Resources on Overcoming Challenges
  • Medical Ethics - The Doctrine of Double Effects
  • Police Accountability Bill
  • COVID-19 Managing Responses to Policies on Vaccinations
  • 'The unvaccinated are not a monolith': Reporters dig into why people delay getting the shot
  • How Teachers Can Manage Burnout During the Pandemic | Rutgers University
  • 5 Things To Know About the Delta Variant
  • Majority of unvaccinated Americans believe COVID-19 vaccines are riskier than infection
  • Debate Is Over: COVID Vax Doubled Protection for the Previously Infected
  • Strong-Arm Tactics Won't Get America Vaccinated
  • COVID-19 Update on Current Challenges and Responses
  • COVID-19 vaccines greatly reduce hospitalization risk
  • COVID19 Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths
  • TRUTH EVER TRIUMPHS 09 11 20
  • Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients
  • Largest real-world study of COVID-19 vaccine safety published
  • FDA Approves Pfizer Booster Shots For Americans Over 65 and Those at High Risk
  • COVID-19 ARC Forum 9-9-2021
  • Gandhi Four Hymns for fulfilled life:
  • Med Talk- Gandhhi Darshan-Connecticut College
  • ARC Health Promotion Response to Food and Nutrition Service
  • Treatment Recommendations for Restoring Wellbeing
  • Massachusetts General Hospital- Spiritual Care Spiritual resources for Hard Times
  • COVID-19 CDC Decision on Booster Dose
  • Covid-19 origins: Why the search for the source is vital - CNN
  • Health Promotion - Educational Materials
  • 5 Ways to Prevent Dementia, Says Dr. Sanjay Gupta
  • Health Promotion: Covid 19 & Alzheimers Share Genetic Risk Factor
  • Six Tips to enhance Immunity
  • Increased White Blood Cell Count May Be Tied To Increased Depression Polygenic Scores
  • Response to Elon Musk and World Food Program: Solve World Hunger
  • Covid 19 - Delta-Omicron- Beta variants
  • Human Immune System - WebMD
  • COVID-19 Vaccinations and sustaining robust levels on nAb
  • Health Promotion Diets affect Intestinal Cells structure and function
  • Non Dairy Yogurt Options
  • MH Resources
  • COVID- 19 Dr Kesslers interview with Maddow on Managing risks plusTony Fauci-Vivek Murthy-Rochelle Walensky
  • COVID19-Five Reports on Issues with CDC 12/27/21 recommendations
  • COVID19-Risk of COVID19 Death nearly 4X Higher in Schizophrenics
  • Dharma-Response to Calls for Genocide in the Name of Hindu Dharma
  • COVID19-Can You Leave Isolation After 5 Days?
  • Afghanistan Advocacy 12/21/21
  • Classical Music list and resources to restoration of well-being,
  • Managing Risks of Omicron Variant in Community - Issues with CDC Guidelines
  • COVID19-Isolation Should Not Be "One Size fits All" Amesh Aldeja
  • Health Promotion Recomendations - Belly Fat and associated issues
  • How Omicron Symptoms Differ From Delta, Past COVID-19 Variants: Charts
  • Testing Could Help End the Pandemic, if Only We Had Tests
  • Pooja Vidhanam
  • Letter to PM re: Narayana Guru
  • India must revive Santan Dharma Principles
  • Stop the Shooter - Stop the Bleed
  • Strategies to adopt Countermeasures to Stop the Shooters from achieving their gory goals
  • Impact of Gun Ownership Patterns and Availability of Firearms to Children 1-18 in the USA
  • Veterans' Health-Engagements Part 1
  • Vetrans' Health - Camp Lejeune_Janey Ensminger
  • Vetrans' Health- Personality Disorder Discharges
  • Vetrans' Health_Personality Disorder Discharges Part2
  • Vetrans' Heath Part 3
  • Vetrans' Health - Stand Down / Memorial Day Parade
  • Vetrans' Health - Marine Corp League
  • American gun violence has immense costs beyond the death toll
  • Uvalde shooter exhibited '"almost every warning sign"
  • SANATANA DHARMA VAK - MOKSHA NAAVAM
  • Sadhana Path - The eBook
  • Temple Book- Touchstones on the path from despondency to liberation andTranscendence
  • Reflections on a well lived life of my Pooja Poocha [Cat]RIP
  • Mindfulness, and Self-Regulation resources
  • The Wonder of It All, Amen
  • Book Promotion 2023
  • Foundational Truths exemplified in the eBook Sadhana Path
  • Response to Hon PM of India’s visit to the UN and State Visit to USA.
  • Atma Nirbhar Abiyaan-Comprehensive perspective
  • Response to Teaching: BHAGVAD GITA CHAPTER 18
  • Srimad Bhagavad Gita: Teachings on Gunas.
  • Epigenetic Changes can impact health and longevity but is reversible
  • Atlas of differential diagnoses:
Velandy Manohar, MD
93, Meeting house road
Haddam, CT 06438
[email protected]

SARS-CoV-2 Transmission From People Without COVID-19 Symptoms

SARS-CoV-2 Transmission From People Without COVID-19 Symptoms | Infectious Diseases | JAMA Network Open | JAMA Network

Original Investigation 

January 7, 2021

SARS-CoV-2 Transmission From People Without COVID-19 Symptoms

Michael A. Johansson, PhD1,2; Talia M. Quandelacy, PhD, MPH1; Sarah Kada, PhD1; et al

AMA Netw Open. 2021;4(1):e2035057. doi:10.1001/jamanetworkopen.2020.35057

Key Points

Question  What proportion of coronavirus disease 2019 (COVID-19) spread is associated with transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from persons with no symptoms?

Findings  In this decision analytical model assessing multiple scenarios for the infectious period and the proportion of transmission from individuals who never have COVID-19 symptoms, transmission from asymptomatic individuals was estimated to account for more than half of all transmission.

Meaning  The findings of this study suggest that the identification and isolation of persons with symptomatic COVID-19 alone will not control the ongoing spread of SARS-CoV-2.

Abstract

Importance  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiology of coronavirus disease 2019 (COVID-19), is readily transmitted person to person. Optimal control of COVID-19 depends on directing resources and health messaging to mitigation efforts that are most likely to prevent transmission, but the relative importance of such measures has been disputed.

Objective  To assess the proportion of SARS-CoV-2 transmissions in the community that likely occur from persons without symptoms.

Design, Setting, and Participants  This decision analytical model assessed the relative amount of transmission from pre-symptomatic, never symptomatic, and symptomatic individuals across a range of scenarios in which the proportion of transmission from people who never develop symptoms (i.e, remain asymptomatic) and the infectious period were varied according to published best estimates. For all estimates, data from a meta-analysis was used to set the incubation period at a median of 5 days. The infectious period duration was maintained at 10 days, and peak infectiousness was varied between 3 and 7 days (−2 and +2 days relative to the median incubation period). The overall proportion of SARS-CoV-2 was varied between 0% and 70% to assess a wide range of possible proportions.

Main Outcomes and Measures  Level of transmission of SARS-CoV-2 from pre-symptomatic, never symptomatic, and symptomatic individuals.

Results  The baseline assumptions for the model were that peak infectiousness occurred at the median of symptom onset and that 30% of individuals with infection never develop symptoms and are 75% as infectious as those who do develop symptoms. Combined, these baseline assumptions imply that persons with infection who never develop symptoms may account for approximately 24% of all transmission. In this base case, 59% of all transmission came from asymptomatic transmission, comprising 35% from presymptomatic individuals and 24% from individuals who never develop symptoms. Under a broad range of values for each of these assumptions, at least 50% of new SARS-CoV-2 infections was estimated to have originated from exposure to individuals with infection but without symptoms.

Conclusions and Relevance  In this decision analytical model of multiple scenarios of proportions of asymptomatic individuals with COVID-19 and infectious periods, transmission from asymptomatic individuals was estimated to account for more than half of all transmissions. In addition to identification and isolation of persons with symptomatic COVID-19, effective control of spread will require reducing the risk of transmission from people with infection who do not have symptoms. These findings suggest that measures such as wearing masks, hand hygiene, social distancing, and strategic testing of people who are not ill will be foundational to slowing the spread of COVID-19 until safe and effective vaccines are available and widely used.

Introduction

As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus that causes coronavirus disease 2019 (COVID-19), began to spread globally, it became apparent that the virus, unlike the closely related SARS-CoV in the 2003 outbreak, could not be contained by symptom-based screening alone. Asymptomatic and clinically mild infections were uncommon during the 2003 SARS-CoV outbreak, and there were no reported instances of transmission from persons before the onset of symptoms.1 SARS-CoV-2 spread faster than SARS-CoV, and accumulating evidence showed that SARS-CoV-2, unlike SARS-CoV, is transmitted from persons without symptoms. However, measures to reduce transmission from individuals who do not have COVID-19 symptoms have become controversial and politicized and have likely had negative effects on the economy and many societal activities. Optimal control of COVID-19 depends on directing resources and health messaging to mitigation efforts that are most likely to prevent transmission. The relative importance of mitigation measures that prevent transmission from persons without symptoms has been disputed. Determining the proportion of SARS-CoV-2 transmission that occurs from persons without symptoms is foundational to prioritizing control practices and policies.

Transmission by persons who are infected but do not have any symptoms can arise from 2 different infection states: presymptomatic individuals (who are infectious before developing symptoms) and individuals who never experience symptoms (asymptomatic infections, which we will refer to as never symptomatic). Early modeling studies of COVID-19 case data found that the generation interval of SARS-CoV-2 was shorter than the serial interval, indicating that the average time between 1 person being infected and that person infecting someone else was shorter than the average time between 1 person developing symptoms and the person they infected developing symptoms.2-5 This finding meant that the epidemic was growing faster than would be expected if transmission were limited to the period of illness during which individuals were symptomatic. By the time a second generation of individuals was developing symptoms, a third generation was already being infected. Epidemiological data from early in the pandemic also suggested the possibility of pre-symptomatic transmission,6,7 and laboratory studies confirmed that levels of viral RNA in respiratory secretions were already high at the time of symptom onset.8-10

Asymptomatic SARS-CoV-2 transmission also occurs because of individuals with infection who are never symptomatic (or who experience very mild or almost unrecognizable symptoms). The proportion of individuals with infection who never have apparent symptoms is difficult to quantify because it requires intensive prospective clinical sampling and symptom screening from a representative sample of individuals with and without infection. Nonetheless, evidence from household contact studies indicates that asymptomatic or very mild symptomatic infections occur,11-14 and laboratory and epidemiological evidence suggests that individuals who never develop symptoms may be as likely as individuals with symptoms to transmit SARS-CoV-2 to others.[Equal level of risk. VM.]9,15,16

Methods

The Centers for Disease Control and Prevention determined that this decision analytical study, which involved no enrollment of human subjects, did not require institutional review board approval. We used a simple model to assess the proportion of transmission from pre-symptomatic (ie, infectious before symptom onset), never symptomatic, and symptomatic individuals across a range of scenarios in which we varied the timing of the infectious period to assess different contributions of pres-ymptomatic transmission and the proportion of transmission from individuals who never develop symptoms (i.e., remain asymptomatic).

For all estimates we used data from a meta-analysis of 8 studies from China to set the incubation period at a median of 5 days with 95% of symptomatic individuals developing symptoms by day 12.17 Therefore the daily (t) probability of symptom onset (pso) for individuals who develop symptoms was:

Statistical Analysis

All analyses were conducted in R version 4.0.1 (R Project for Statistical Computing). No statistical testing was conducted, so no prespecified level of significance was set.

Results

Under baseline assumptions, approximately 59% of all transmission came from asymptomatic transmission: 35% from pre-symptomatic individuals and 24% from individuals who are never symptomatic (Figure 1). Because each component is uncertain, we assessed different timings of peak infectiousness relative to illness onset and different proportions of transmission from individuals who never have symptoms. Maintaining the 24% of transmission from individuals who never have symptoms, but shifting peak infectiousness 1 day earlier (to day 4) increased pre-symptomatic transmission to 43% and all asymptomatic transmission to 67% (Figure 1A). A later peak (i.e., day 6) decreased pre-symptomatic to 27% and all asymptomatic transmission to 51% (Figure 1C).

Holding the day of peak infectiousness constant at day 5 and decreasing the proportion of transmission from individuals who are never symptomatic to 10% with a relative infectiousness of 75% (baseline assumption), the proportion of all transmission from those who are never symptomatic decreased to 8%, pre-symptomatic transmission increased to 42%, and combined asymptomatic transmission was 50% of all transmission (Figure 1D). In contrast, if the proportion of those who ever develop symptoms was 30% and their relative infectiousness increased to 100%, they contributed 30% of all transmission, pre-symptomatic transmission was 32%, and combined asymptomatic transmission was 62% of all transmission (Figure 1F).

Uncertainty remains regarding the magnitude of both pre-symptomatic and never symptomatic transmission. Therefore, we analyzed a wider range of each of these components, with peak infectiousness varying between 2 days before (more presymptomatic transmission) to 2 days after (less pre-symptomatic transmission) median symptom onset and with never symptomatic transmission ranging from 0% to 70% (Figure 2). Under this broader range of scenarios, most combined assumptions of peak infectiousness timing and transmission from individuals who never have symptoms indicated that at least 50% of new SARS-CoV-2 infections likely originated from individuals without symptoms at the time of transmission. If more than 30% of transmission was from individuals who never have symptoms, total asymptomatic transmission was higher than 50% with any value of peak infectiousness, up to 2 days after the median time of symptom onset. If peak infectiousness was at any point approximately 6 hours before median symptom onset time, more than 50% of transmission was from individuals without symptoms, regardless of the proportion from those who never have symptoms. Even a very conservative assumption of peak infectiousness 2 days post–median onset and 0% never symptomatic transmission still resulted in more than 25% of transmission from asymptomatic individuals.

Discussion

The findings presented here complement an earlier assessment21 and reinforce the importance of asymptomatic transmission: across a range of plausible scenarios, at least 50% of transmission was estimated to have occurred from persons without symptoms. This overall proportion of transmission from pre-symptomatic and never symptomatic individuals is key to identifying mitigation measures that may be able to control SARS-CoV-2. For example, if the reproduction number (R) in a given setting is 2.0, then at least a 50% reduction in transmission is needed to drive the reproductive number below 1.0. Given that in some settings R is likely much greater than 2 and more than half of transmissions may come from individuals who are asymptomatic at the time of transmission, effective control must mitigate transmission risk from people without symptoms.

Limitations

This study has limitations. First, we used a simplistic model to represent a complex phenomenon, ie, the average infectiousness of SARS-CoV-2 infections over time. We used this model deliberately to test assumptions about the timing of peak infectiousness and transmission among asymptomatic individuals so that we could vary only these 2 critical parameters and assess their relative effects. Therefore, these results lack quantitative precision, but they demonstrate the qualitative roles of these 2 components and show that across broad ranges of possible assumptions, the finding that asymptomatic transmission is a critical component of SARS-CoV-2 transmission dynamics remains constant.

As discussed here, the exact proportions of pre-symptomatic and never symptomatic transmission are not known. This also applies to the incubation period estimates, which are based on individual exposure and onset windows that are difficult to observe with precision and therefore include substantial uncertainty even when leveraging estimates across multiple studies. Moreover, they likely vary substantially in different populations. For example, older individuals are more likely than younger persons to experience symptoms,20 so in populations of older individuals, never asymptomatic transmission may be less important. However, specific age groups are rarely exclusively isolated from other age groups, so asymptomatic transmission risk is still important in those groups and even more so in younger age groups, in which transmission may be even more dominated by asymptomatic transmission.20

Real-world transmission dynamics are also not entirely dependent on the individual-level dynamics of infectiousness over time. Now that COVID-19 is widely recognized, individuals with COVID-19 symptoms are more likely to isolate themselves and further reduce the proportion of transmission from symptomatic individuals, shifting a greater proportion of transmission to those who do not have symptoms. In this sense, the estimates here represent the lower end of the proportion of asymptomatic transmission in the presence of interventions to reduce symptomatic transmission.

Conclusions

Under a range of assumptions of pre-symptomatic transmission and transmission from individuals with infection who never develop symptoms, the model presented here estimated that more than half of transmission comes from asymptomatic individuals. In the absence of effective and widespread use of therapeutics or vaccines that can shorten or eliminate infectivity, successful control of SARS-CoV-2 cannot rely solely on identifying and isolating symptomatic cases; even if implemented effectively, this strategy would be insufficient. These findings suggest that effective control also requires reducing the risk of transmission from people with infection who do not have symptoms. Measures such as mask wearing and social distancing empower individuals to protect themselves and, if infected, to reduce risk to their communities.21 These measures can also be supplemented by strategic testing of people who are not ill, such as those who have exposures to known cases (eg, contact tracing) or are at high risk of exposing others (eg, congregate facility staff, those with frequent contact with the public). Multiple measures that effectively address transmission risk in the absence of symptoms are imperative to control SARS-CoV-2.

Accepted for Publication: December 7, 2020.

Corresponding Author: Jay C. Butler, MD, Office of the Deputy Director for Infectious Diseases, US Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop H24-12, Atlanta, GA 30329 ([email protected]).

Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.

Disclaimer
af85ad9eae708e5da5e8224db764e774